Zentek (CVE:ZEN) Director Mohammed Jiwan Acquires 11,000 Shares

Zentek Ltd. (CVE:ZEN - Get Free Report) Director Mohammed Jiwan bought 11,000 shares of the firm's stock in a transaction on Wednesday, December 31st. The stock was purchased at an average price of C$0.93 per share, with a total value of C$10,230.00. Following the transaction, the director owned 22,000 shares in the company, valued at C$20,460. The trade was a 100.00% increase in their position.Zentek Stock PerformanceShares of ZEN remained flat at C$0.91 during mid-day trading on Wednesday. The stock had a trading volume of 23,946 shares, compared to its average volume of 47,973. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97. The firm's 50 day simple moving average is C$1.07 and its 200-day simple moving average is C$1.19. The company has a market cap of C$97.65 million, a PE ratio of -10.11 and a beta of 0.42. Zentek Ltd. has a 52 week low of C$0.85 and a 52 week high of C$2.50. About Zentek (Get Free Report)Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.See AlsoFive stocks we like better than ZentekDo not delete, read immediatelyThe Crash Has Already Started (Most Just Don’t See It Yet)ALERT: Drop these 5 stocks before January 2026![No Brainer Gold Play]: “Show me a better investment.”INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Zentek Right Now?Before you consider Zentek, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here